releases: https://www.mccaskill.senate.gov/media-center/news-releases/following-mccaskill-oversight-administration-increases-transparency-on-federal-healthcare-enforcement
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://www.mccaskill.senate.gov/media-center/news-releases/following-mccaskill-oversight-administration-increases-transparency-on-federal-healthcare-enforcement | Following McCaskill Oversight, Administration Increases Transparency on Federal Healthcare Enforcement | 2018-10-01 | 2018 | 2018-10 | Democrat | House | MO | Claire McCaskill | M001170 | www.mccaskill.senate.gov | legacy | Following McCaskill Oversight, Administration Increases Transparency on Federal Healthcare Enforcement Information on enforcement actions by the Department of Health and Human Services Office of Inspector General against healthcare providers or other entities misusing taxpayer funds now publicly available in response to Senator's request Monday, October 1, 2018 WASHINGTON Followinga requestfrom U.S. Senator Claire McCaskill, the Department of Health and Human Services Office of Inspector General recently announced that it had implemented plans to increase transparency on its previous enforcement actions. McCaskill asked for this change earlier this year when a Government Accountability Officereport, also requested by McCaskill, showed that there was no public record of compliance agreements with healthcare providers or other entities that engaged in waste, fraud, or abuse of federal healthcare dollars after they expire. Healthcare is the number one issue for many Missourians, who are worried about how they're going to afford a visit to the doctor's office or emergency room, said McCaskill, the top-ranking Democrat on the Homeland Security and Governmental Affairs Committee. Taxpayers deserve to know when healthcare providers have essentially been repeat offenders or prior offenders, and this transparency will help achieve that goal. The Government Accountability Office report requested by McCaskill analyzed the Department of Health and Human Services' use of corporate integrity agreements, which the agency can impose on healthcare providers or other entities that have violated federal law or regulations in their delivery of health services or products that were paid for by the federal government. These integrity agreements allow the agency's Office of Inspector General to enact penalties and/or monitor the providers as they continue to deliver health services. However, when these agreements expired, there was no public record of themdenying government agencies, state governments, or individuals access to enforcement histories for healthcare providers or vendors. McCaskill has long been an advocate for increased transparency in government and in healthcare spending. Last week, McCaskillreleased a draft bipartisan planto help protect patients from surprise medical bills, which comes from the bipartisan Senatehealthcare price transparency working group, of which McCaskill is a member. Last month, shereleased an investigative reportthat showed that drug prices directly negotiated by the government could save the Medicare Part D program $2.8 billion in a single year on the 20 most commonly prescribed brand-name drugs alone. As part of her investigation into opioid manufacturers and distributorsthe most comprehensive Congressional investigation into the crisis to dateMcCaskillexposed the financial tiesbetween opioid manufacturers and third party groups, who often lobbied for pro-opioid policies after receiving contributions from pharmaceutical companies. In the wake of these discoveries, McCaskillintroduced a billin June to increase transparency and ensure opioid manufacturers report contributions to third party groups, which totaled almost $9 million between 2012 and 2017 for the companies and groups profiled in the February 2018 report. Read HHS OIG's letter to McCaskill announcing this changeHERE. ### Print Email Tweet | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |